| payload |
{"created_at":"2026-04-11T03:10:51.104 {"created_at":"2026-04-11T03:10:51.104915+00:00","dedupe_key":"signal_enriched:discovery_sec_filing_delta:66e890eb85ac0065","evidence_event_ids":["evt_548a9b602557"],"signal_type":"discovery_sec_filing_delta","source":"discovery_sec_filings","value":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1840706/0001840706-26-000137.txt","as_of":"2026-04-11T03:10:51.104915+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1840706/0001840706-26-000137.txt","company":"SOPHiA GENETICS SA","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1840706/0001840706-26-000137.txt","article_chars":2693,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_d7e0c2ae23c5785c","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1840706/0001840706-26-000137.txt","content_type":"text/plain","enriched_at":"2026-04-11T07:35:15.672984+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1840706/0001840706-26-000137.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1840706/0001840706-26-000137.txt","source_event_id":"evt_548a9b602557","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"531c11f874450de6","kind":"sec_filing","published_at":"20260410","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-10","2026-04-08","2026-04-09","2026-04-02","2026-04-03"],"entities":[{"asset_class":"equity","name":"SOPHiA GENETICS SA","relevance":"high","symbol":"","type":"issuer"},{"asset_class":"equity","name":"Daan van Well","relevance":"high","symbol":"","type":"reporting_owner"},{"asset_class":"equity","name":"SOPHiA GENETICS SA ordinary shares","relevance":"high","symbol":"","type":"security"}],"event_type":"listing","information_gaps":["No prior known state is provided in the signal, so the specific 'delta vs prior' change cannot be determined beyond the fact that this Form 4 was filed.","No explicit total shares sold across both dates is stated in a single line (though it can be inferred from the two quantities; inference is not performed here).","No disclosure of whether any other reporting persons or additional transactions are included beyond what appears in the cleaned text."],"key_facts":["SEC filing type: Form 4 (Conformed submission type: 4).","Issuer: SOPHiA GENETICS SA (CIK: 0001840706).","Reporting owner: Van Well Daan (CIK: 0002006414).","Reporting owner title shown: Chief Legal Officer.","Filing accession number: 0001840706-26-000137.","Conformed period of report: 20260408; filed as of date: 20260410.","Shares sold: 2,861 ordinary shares with a weighted average price of 4.8452 (date shown: 2026-04-08).","Shares sold: 1,988 ordinary shares with a weighted average price of 4.7406 (date shown: 2026-04-09).","Footnote states the sales were to satisfy tax withholding obligations arising from vesting of restricted stock units on April 2 and 3, 2026.","Footnote states sales were effected pursuant to a pre-established Rule 10b5-1 trading plan and were not discretionary trades.","Footnote states reported prices are weighted averages and sales occurred in multiple transactions within stated price ranges (first range: $4.78 to $4.94; second range: $4.61 to $4.86).","Footnote states the reporting person will provide full information on number of shares sold at each separate price within the range upon written request to the issuer/security holders/SEC staff."],"numeric_claims":[{"label":"Shares sold (2026-04-08)","value":"2861"},{"label":"Weighted average price (2026-04-08)","value":"4.8452"},{"label":"Shares sold (2026-04-09)","value":"1988"},{"label":"Weighted average price (2026-04-09)","value":"4.7406"},{"label":"Price range (2026-04-08 transactions)","value":"$4.78 to $4.94"},{"label":"Price range (2026-04-09 transactions)","value":"$4.61 to $4.86"}],"primary_claim":"The reporting person (Daan van Well) sold SOPHiA GENETICS SA ordinary shares to satisfy tax withholding obligations tied to restricted stock unit vesting, under a pre-established Rule 10b5-1 trading plan.","relevance_score":0.55,"sentiment":"neutral","source_quality":"high","summary":"SOPHiA GENETICS SA filed a Form 4 on 2026-04-10 covering sales of ordinary shares by reporting owner Daan van Well on 2026-04-08 and 2026-04-09. The filing states the sales were to satisfy tax withholding obligations related to vesting of restricted stock units and were executed under a Rule 10b5-1 trading plan.","topics":["SEC Form 4","insider trading","Rule 10b5-1 plan","tax withholding","restricted stock units (RSUs)","ordinary shares sales"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 SOPHiA GENETICS SA \u00b7 Filed 20260410","ticker":"SOPH","tickers":["SOPH"],"title":"SOPH filed 4","url":"https://www.sec.gov/Archives/edgar/data/1840706/0001840706-26-000137.txt"}}... |